Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Express Scripts
Colorcon
Daiichi Sankyo
McKesson
Baxter
Queensland Health
Merck
Cipla

Generated: February 16, 2019

DrugPatentWatch Database Preview

Alkem Labs Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for ALKEM LABS LTD, and what generic and branded alternatives to ALKEM LABS LTD drugs are available?

ALKEM LABS LTD has thirty-eight approved drugs.

There are seven tentative approvals on ALKEM LABS LTD drugs.

Summary for Alkem Labs Ltd
US Patents:0
Tradenames:35
Ingredients:35
NDAs:38

Drugs and US Patents for Alkem Labs Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd OLANZAPINE olanzapine TABLET;ORAL 202295-004 Oct 20, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Alkem Labs Ltd LAMOTRIGINE lamotrigine TABLET;ORAL 200694-003 Jun 14, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Alkem Labs Ltd TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 207651-002 Dec 26, 2017 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Alkem Labs Ltd RILUZOLE riluzole TABLET;ORAL 204048-001 Mar 30, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Alkem Labs Ltd FINASTERIDE finasteride TABLET;ORAL 207750-001 Jan 6, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Dow
Express Scripts
Julphar
Mallinckrodt
Accenture
Chinese Patent Office
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.